Mitral Stenosis Clinical Trial
Official title:
French National Observatory of Percutaneous Mitral Commissurotomy (PMC) Immediate Score, Scanner, Late Results
The aim of this study is to validate prospectively the predictive score of late results about a diverse population recruited in France and to evaluate the contribution in predicting the outcome of the PMC scanner to study the mitral calcium score and the location of the calcifications.
This is a multicenter prospective observational study conducted in French medico-surgical sites. The Percutaneous Mitral Commissurotomy (PMC) is the standard treatment for Mitral stenosis (MS) in patients with rheumatic favorable characteristics. In Western countries the MS reaches older patients with less favorable characteristics, including the presence of mitral calcifications. Calcifications are a factor of poor outcome of the PMC. The scanner appears as a useful examination for their study but is not carried out systematically. The prediction of late results of the PMC is particularly important in patients with non-ideal characteristics which form a particularly heterogeneous population. A score of late results of the PMC on the wider western series was recently released but has not to date received external validation. In this score, prediction results was multifactorial, with a consideration of paramount clinical factors, but also a prognostic significance of mitral calcifications. The validation of predictive score of late results of the PMC, with the analysis of calcifications, would better select patients who may best benefit from PMC and those for which the surgical management is preferred. The aim of this study is to validate an external sample predictive score of the event-free survival in patients who have had a good immediate result of the PMC. This study, purely observational, does not create any special procedure outside the patient's usual care. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06167213 -
ALLIANCE Mitral: Safety and Effectiveness of SAPIEN X4 Transcatheter Heart Valve - Mitral
|
N/A | |
Completed |
NCT02188862 -
Genetic Susceptibility to Rheumatic Heart Disease in the Pacific Region
|
N/A | |
Recruiting |
NCT04045093 -
Dabigatran for Mitral Stenosis Atrial Fibrillation
|
Phase 4 | |
Recruiting |
NCT05625607 -
Polish Transcatheter Transfemoral Mitral Valve-in-Valve Implantation (Mitral ViV) Registry
|
||
Not yet recruiting |
NCT06067815 -
Assessment of Right Ventricular Function in Patients With Severe Mitral Stenosis Before and After Balloon Mitral Valvuloplasty
|
||
Completed |
NCT01022463 -
Effect of Ivabradine on Heart Rate & Effort Tolerance in Mitral Stenosis in Sinus Rhythm
|
Phase 3 | |
Terminated |
NCT03926156 -
RIvoraxaban in Mitral Stenosis
|
Phase 3 | |
Not yet recruiting |
NCT06377449 -
Influence of Lung Ultrasonography on the Prognosis and Postoperative Outcomes in Cardiac Surgical Patients
|
N/A | |
Recruiting |
NCT04408430 -
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
|
N/A | |
Active, not recruiting |
NCT06191718 -
Clinical Investigation for the Foldax Tria Mitral Valve- India
|
N/A | |
Recruiting |
NCT03991910 -
The Effect of Ramipril in Suppressing ST2 Expression in Rheumatic Mitral Stenosis Patients
|
Phase 3 | |
Recruiting |
NCT05925335 -
The China Mviv Registry
|
N/A | |
Not yet recruiting |
NCT06340997 -
Impact of Percutaneous Transvenous Mitral Commissurotomy on The Left Atrial Appendage Function in Patients With Mitral Stenosis.
|
N/A | |
Completed |
NCT02502448 -
Acute Normovolemic Hemodilution on ROTEM in Cardiac Surgery
|
N/A | |
Completed |
NCT04527367 -
Epidemiology and Long-term Outcome of Patients With VHD
|
||
Active, not recruiting |
NCT05526560 -
Real-world Clinical Outcomes of the MITRIS RESILIA Mitral Valve
|
||
Completed |
NCT06371222 -
Role of Ivabradine on Heart Rate and Quality of Life in Patients With Mitral Stenosis in Sinus Rhythm
|
Phase 4 | |
Completed |
NCT02831270 -
Acute Normovolemic Hemodilution on Serum-creatinine Concentration in Cardiac Surgery
|
N/A | |
Recruiting |
NCT01270750 -
Bosentan for Severe Mitral Valve Dysfunction
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT01757665 -
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
|
N/A |